ContraFect Reports Third Quarter 2019 Financial Results and Provides Business Update

    NEXT STORY
    Forty Seven, Inc. Reports Third Quarter 2019 Financial Results and Recent Business Highlights
    PREV STORY
    BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunomedics Announces Publication of Phase 2 Results With Labetuzumab Govitecan (IMMU-130) That Demonstrate Promising Efficacy as a Single Agent in Patients With Metastatic Colorectal Cancer

    MORRIS PLAINS, N.J., Aug. 21, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or ...

    author_avatar
    NASDAQ Market News

    Aptose Biosciences and CrystalGenomics Announce Issuance of Japanese Patent for CG-806

    SAN DIEGO, TORONTO, and SEOUL, July 10, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ...

    author_avatar
    NASDAQ Market News

    Cue Biopharma to Present Corporate Overview and Update at the Oppenheimer 29th Annual Healthcare Conference

    author_avatar
    NASDAQ Market News